AXGN
AXGN clinical trials: Axogen, Inc.
Every trial on ClinicalTrials.gov where Axogen, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 14
- Trials linked
- 10
- As lead sponsor
- 4
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
AXGN on the catalyst calendar · AXGN registry changes
- Primary completion Dec 5, 2030Sponsor estimatePhase 4NCT07657182Study Comparing Avance Nerve Graft and Autograft for Functional Recovery Following Mixed and Motor Peripheral Nerve ReconstructionAxogen Corporation · Peripheral Nerve InjuryRecruitingAXGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 17, 2026ActualNo phase registeredNCT06117501Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome DecompressionAxogen Corporation · Recurrent Cubital Tunnel SyndromeCompletedAXGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimateNo phase registeredNCT04865679Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve EndsAxogen Corporation · Symptomatic NeuromaActive, not recruitingAXGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2028Sponsor estimateNo phase registeredNCT01526681Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve ReconstructionAxogen Corporation · Peripheral Nerve InjuriesActive, not recruitingAXGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 17, 2020ActualNo phase registeredNCT03943134Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper ExtremityAxogen Corporation · Acute Upper Extremity TraumaTerminatedAXGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 17, 2023ActualNo phase registeredNCT03940963Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma PainAxogen Corporation · Symptomatic NeuromaCompletedAXGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2015ActualPhase 4NCT00953277Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate CancerAxogen Corporation · Peripheral Nerve InjuryCompletedAXGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 24, 2024ActualNo phase registeredNCT04287075Surgical Treatment of Chronic Neuropathic PainAxogen Corporation · Chronic Neuropathic PainTerminatedAXGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 30, 2021ActualPhase 3NCT01809002Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve RepairAxogen Corporation · Peripheral Nerve DiscontinuitiesCompletedAXGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2014ActualNo phase registeredNCT00948025A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair OptionsAxogen Corporation · Traumatic Nerve InjuryTerminatedAXGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2029Sponsor estimateNo phase registeredNCT07941011Hyaluronic Acid Barrier in ParotidectomyMilton S. Hershey Medical Center · Parotidectomy, Patient-reported OutcomesNot yet recruitingAXGNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2027Sponsor estimateNo phase registeredNCT07283861Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck DissectionMatthew Spector · Head and Neck CancerActive, not recruitingAXGNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 11, 2024ActualNo phase registeredNCT04533373Sensory Restoration After DIEP Flap NeurotizationJohns Hopkins University · Breast CancerTerminatedAXGNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 25, 2019ActualNo phase registeredNCT03909464Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral NeuropathySidney Kimmel Comprehensive Cancer Center at Johns Hopkins · CancerCompletedAXGNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 14 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner